P. Repoussis

发表

Clinical characteristics and outcome of primary systemic light-chain amyloidosis in Greece.

M. Dimopoulos, E. Kastritis, M. Kyrtsonis, 2010, Clinical lymphoma, myeloma & leukemia.

Veno-occlusive Disease of the Liver after Blood and Marrow Transplantation: Analysis of Pre- and Post-transplant Risk Factors Associated with Severity and Results of Therapy with Tissue Plasminogen Activator

K. Batts, P. Anderson, A. Tefferi, 2002, Leukemia & lymphoma.

Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy in primary mediastinal large B-cell lymphoma: the emerging standard of care.

M. Dimopoulos, M. Angelopoulou, G. Pangalis, 2012, The oncologist.

Acute Promyelocytic Leukemia: an Experience on 95 Greek Patients Treated in the All-Trans-Retinoic Acid Era

K. Manola, P. Tsirigotis, C. Prokopiou, 2011, Mediterranean journal of hematology and infectious diseases.

Dexamethasone, rituximab, and cyclophosphamide as primary treatment of Waldenström macroglobulinemia: final analysis of a phase 2 study.

M. Dimopoulos, E. Kastritis, M. Gavriatopoulou, 2015, Blood.

Primary treatment of Waldenström macroglobulinemia with dexamethasone, rituximab, and cyclophosphamide.

M. Dimopoulos, M. Kyrtsonis, A. Vassou, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

No significant improvement in the outcome of patients with Waldenström's macroglobulinemia treated over the last 25 years

M. Dimopoulos, K. Konstantopoulos, T. Economopoulos, 2010, American journal of hematology.

Prognostication of the high-risk WM patient.

M. Dimopoulos, K. Konstantopoulos, T. Economopoulos, 2011, Clinical Lymphoma, Myeloma & Leukemia.

Validation of the International Prognostic Scoring System (IPSS) for Waldenstrom's macroglobulinemia (WM) and the importance of serum lactate dehydrogenase (LDH).

M. Dimopoulos, E. Kastritis, M. Gavriatopoulou, 2009, Leukemia research.

Prognostication in young and old patients with Waldenström's macroglobulinemia: importance of the International Prognostic Scoring System and of serum lactate dehydrogenase.

M. Dimopoulos, E. Kastritis, A. Vassou, 2009, Clinical lymphoma & myeloma.

Primary Treatment of Waldenstrom’s Macroglobulinemia (WM) with Dexamethasone, Rituximab and Cyclophosphamide.

M. Dimopoulos, T. Economopoulos, M. Kyrtsonis, 2004 .

Primary Treatment of Waldenstrom's Macroglobulinemia with Dexamethasone, Rituximab and Cyclophosphamide (DRC): Final Analysis of a Phase II Study

M. Dimopoulos, E. Kastritis, M. Gavriatopoulou, 2012 .

Primary treatment with pulsed melphalan, dexamethasone and thalidomide for elderly symptomatic patients with multiple myeloma.

M. Dimopoulos, M. Kyrtsonis, A. Vassou, 2006, Haematologica.

Macrofocal multiple myeloma in young patients: A distinct entity with favorable prognosis

M. Dimopoulos, E. Terpos, A. Anagnostopoulos, 2005, Leukemia & lymphoma.